Page last updated: 2024-11-01

nimodipine and Alogia

nimodipine has been researched along with Alogia in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larrosa-Campo, D1
Ramon-Carbajo, C1
Benavente-Fernandez, L1
Alvarez-Escudero, R1
Zeidan-Ramon, N1
Calleja-Puerta, S1
Pascual, J1
Hütter, BO1
Gilsbach, JM1

Other Studies

2 other studies available for nimodipine and Alogia

ArticleYear
[Diagnosis of stroke due to cocaine and its complications].
    Revista de neurologia, 2013, Aug-16, Volume: 57, Issue:4

    Topics: Adult; Aphasia; Cerebrovascular Circulation; Cocaine; Cocaine-Related Disorders; Crack Cocaine; Hemi

2013
Which neuropsychological deficits are hidden behind a good outcome (Glasgow = I) after aneurysmal subarachnoid hemorrhage?
    Neurosurgery, 1993, Volume: 33, Issue:6

    Topics: Adult; Age Factors; Aphasia; Cognition Disorders; Female; Follow-Up Studies; Glasgow Coma Scale; Hum

1993